Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:344-349
Published online before print December 24, 2008, doi: 10.1161/STROKEAHA.108.531079
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/2/344    most recent
STROKEAHA.108.531079v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arenillas, J. F.
Right arrow Articles by Dávalos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arenillas, J. F.
Right arrow Articles by Dávalos, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Metabolic Syndrome
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Risk Factors for Stroke
Right arrow Thrombolysis

(Stroke. 2009;40:344.)
© 2009 American Heart Association, Inc.


Original Contributions

The Metabolic Syndrome Is Associated With a Higher Resistance to Intravenous Thrombolysis for Acute Ischemic Stroke in Women Than in Men

Juan F. Arenillas, MD, PhD; Patricio Sandoval, MD; Natalia Pérez de la Ossa, MD; Mónica Millán, MD; Cristina Guerrero, MD; Domingo Escudero, MD, PhD; Laura Dorado, MD; Elena López-Cancio, MD; José Castillo, MD, PhD Antoni Dávalos, MD, PhD

From the Stroke Unit (J.F.A., P.S., N.P.d.l.O., M.M., C.G., D.E., L.D., E.L.-C., A.D.), Department of Neurosciences, Germans Trias i Pujol Universitary Hospital, Universitat Autònoma de Barcelona, Badalona (Barcelona), Spain; Departmento de Neurología (P.C.), Pontificia Universidad Católica de Chile, Santiago, Chile; Clinical Neuroscience Research Laboratory (J.C.), Division of Vascular Neurology, Department of Neurology, Hospital Clínico Universitario, University of Santiago de Compostela, Santiago de Compostela, Spain; and the Stroke Unit (J.F.A.), Department of Neurology, Hospital Clínico Universitario, University of Valladolid, Valladolid, Spain.

Correspondence to Dr Juan F. Arenillas Lara, Stroke Unit, Department of Neurology, Hospital Clínico Universitario, University of Valladolid, Avda Ramón y Cajal 3, 47005 Valladolid, Spain. E-mail juanfarenillas{at}gmail.com

Background and Purpose— The metabolic syndrome (MetS) might confer a higher resistance to intravenous thrombolysis in acute middle cerebral artery (MCA) ischemic stroke. MetS increases the risk of stroke in women to a greater extent than in men. We aimed to investigate whether there might be sex differences in the impact of MetS on the response to intravenous thrombolysis for acute MCA ischemic stroke.

Methods— We prospectively studied consecutive ischemic stroke patients, treated with intravenous tissue-type plasminogen activator according to SITS-MOST criteria, with an MCA occlusion on prebolus transcranial Doppler examination. Resistance to thrombolysis was defined as the absence of complete MCA recanalization 24 hours after tissue-type plasminogen activator infusion by transcranial Doppler criteria. MetS was diagnosed according to the criteria established by the American Heart Association/National Heart, Lung, and Blood Institute 2005 statement.

Results— A total of 125 patients (75 men, 50 women; mean age, 67.6±11 years) were included. MetS was diagnosed in 76 (61%) patients. Resistance to clot lysis at 24 hours was observed in 53 (42%) patients. Two multivariate-adjusted, logistic-regression models identified that MetS was associated with a higher resistance to tissue-type plasminogen activator, independently of other significant baseline variables (odds ratio=9.8; 95% CI, 3.5 to 27.8; P=0.0001) and of the individual components of the MetS. The MetS was associated with a significantly higher odds of resistance to thrombolysis in women (odds ratio=17.5; 95% CI, 1.9 to 163.1) than in men (odds ratio=5.1; 95% CI, 1.6 to 15.6; P for interaction=0.0004).

Conclusions— The effect of MetS on the resistance to intravenous thrombolysis for acute MCA ischemic stroke appears to be more pronounced in women than in men.


Key Words: acute stroke • thrombolysis • outcome • metabolic syndrome • sex differences




This article has been cited by other articles:


Home page
StrokeHome page
G. Tsivgoulis, K. Voumvourakis, and E. Stamboulis
Sex-Differences in the Impact of Metabolic Syndrome on Tissue Plasminogen Activator-Induced Recanalization
Stroke, April 1, 2009; 40(4): e100 - e100.
[Full Text] [PDF]


Home page
StrokeHome page
J. F. Arenillas, L. Dorado, and A. Davalos
Response to Letter by Tsivgoulis et al
Stroke, April 1, 2009; 40(4): e101 - e102.
[Full Text] [PDF]